Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...

Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY - - Agreement for CASGEVY in transfusion-dependent beta thalassemia (TDT) was previously reached ...

1 Day VRTX -0.71% DJIA 0.38% S&P 500 0.53% Health Care/Life Sciences 0.19% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Get the Real Story Behind Every Major Earnings Report RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

MANILA, Philippines — Opposition to the scheduled increase in member contributions to the Social Security System (SSS) mounted over the weekend as a group of teachers and a former chief ...

The scheduled increase in the contributions of members and employers of up to 15% under the Social Security System (SSS) has taken effect starting January 2025. The increase in contribution rate was ...

MANILA, Philippines — Veteran labor rights advocate Neri Colmenares urges the Social Security System (SSS) to suspend its implementation of higher contribution rates as it will be burden to ...

House Assistant Minority Leader and Gabriela Women's Party-list Rep. Arlene Brosas on Friday cried foul over the Social Security System's (SSS) contribution rate increase, which she described as a ...

SSS MONTHLY CONTRIBUTION 2025 – For employer members of the Social Security System, here is a guide on the contribution rate for next year. One of the giants in terms of social insurance in the ...